IndiaOne Finance - Company Dashboard

Governance Classic Home

Senores Pharmaceuticals LtdPharmaceuticalsINE0RB801010Consolidated₹1405.80+1.00 (+0.07%)Jun-26

Valuation

Market Cap₹6.46K Cr

TTM PE49.39x

Forward PE48.12x

PEG6.48

Book Value₹202.72

P/B6.92x

TTM EPS₹28.40

Fwd EPS₹29.15

TTM Revenue₹691.72 Cr

TTM PAT₹130.82 Cr

TTM EBITDA₹204.76 Cr

TTM EBIT₹169.58 Cr

Last Qtr PAT₹30.45 Cr

Last Qtr EBITDA₹53.76 Cr

Last Qtr EBIT₹43.82 Cr

Profitability

ROE14.01%

ROCE15.62%

TTM NPM18.91%

TTM EBITDA %29.60%

Curr OPM16.64%

Last OPM19.01%

Curr NPM—

Last NPM—

Curr EPS₹6.61

Last EPS₹7.96

Balance sheet

Equity₹46.05 Cr

Reserve₹887.55 Cr

Total Debt₹342.03 Cr

D/E0.37x

Interest %23.55%

Curr Interest₹7.17 Cr

Price / range

Close₹1402.60

vs 52W High—

vs 52W Low—

MA50—

MA200—

Returns

1D0.00%

1W-4.20%

1M-8.60%

3M+6.99%

6M+87.94%

1Y+95.92%

2Y—

3Y—

5Y—

Diwali+69.67%

Sector peers — Pharmaceuticals

Company	Close	Mkt Cap	TTM P/E	ROE
SUNPHARMA	1837.30	₹4.41L Cr	36.45	14.50%
DIVISLAB	9375.00	₹2.49L Cr	85.06	17.45%
TORNTPHARM	4840.00	₹1.84L Cr	77.32	25.70%
ZYDUSLIFE	1160.00	₹1.16L Cr	25.85	16.94%
CIPLA	1394.50	₹1.13L Cr	33.41	9.75%
LAURUSLABS	1954.00	₹1.06L Cr	96.45	20.58%
AUROPHARMA	1734.00	₹99.77K Cr	27.09	9.79%
DRREDDY	1185.00	₹98.91K Cr	30.63	8.40%

Financial Results

Quarterly and yearly P&L · YoY % on Revenue, Total Income, Expenditure, EBITDA, EBIT, PBT, Net Profit and EPS

Metric	Jun-26	Mar-26	Dec-25	Sep-25	Jun-25	FY25-26
Revenue	26.99+36.2%	36.81	28.76	35.33	19.82	106.09
Other Income	9.55	22.19	9.78	11.36	8.39	66.35
Total Income	36.54+29.5%	59	38.54	46.69	28.21	172.44
Interest	2.22	1.89	1.75	1.58	1.76	6.98
Expenditure	-35.15-42.8%	-46.31	-35.02	-39.04	-24.62	-144.98
PBDT	0	0	0	0	0	0
EBITDA	-2.33-100.9%	-3.48	-0.93	1.52	-1.16	-18.68
Depreciation	-3.61	-4.13	-3.58	-3.65	-1.88	-13.23
EBIT	-5.94-95.4%	-7.61	-4.51	-2.13	-3.04	-31.91
PBT	1.39-61.3%	12.69	3.52	7.65	3.59	27.46
Tax	-0.36	-4.21	-0.87	-1.22	-0.89	-7.21
Equity	46.05	46.05	0	0	46.05	46.05
OPM	3.80	21.51	12.24	21.65	12.73	15.92
Net Profit	1.03-61.9%	8.48	2.65	6.43	2.70	20.25
NPM	2.82	14.37	9.21	18.20	9.57	11.74
EPS	0.22-62.7%	1.84	1.98	1.40	0.59	4.40

Yearly results

Last 6 financial years · YoY % vs previous FY

Metric	FY 25-26	FY 24-25
Revenue	106.09+175.3%	38.54
Other Income	66.35	21.99
Total Income	172.44+184.9%	60.53
Expenditure	-144.98-161.6%	-55.42
Interest	-6.98	-6.52
PBDT	0	0
EBITDA	-18.68-156.6%	-7.28
Depreciation	-13.23	-3.08
EBIT	-31.91-208.0%	-10.36
PBT	27.46+437.4%	5.11
Tax	-7.21	-1.42
Equity	46.05	46.05
OPM (%)	15.92	8.44
Net Profit	20.25+448.8%	3.69
NPM (%)	11.74	6.10
EPS (Rs)	4.40+331.4%	1.02
CEPS	4.40	1.02

Metric	Jun-26	Mar-26	Dec-25	Sep-25	Jun-25	FY25-26
Revenue	180.21+30.6%	175.19	174.56	161.76	137.99	632.63
Other Income	2.81	17.67	3.78	5.41	3.36	47.06
Total Income	183.02+29.5%	192.86	178.34	167.17	141.35	679.69
Interest	7.17	8.46	5.33	6.19	5.04	25.03
Expenditure	-143.56-25.0%	-145.46	-133.74	-126.53	-114.86	-520.59
PBDT	0	0	0	0	0	0
EBITDA	53.76+57.3%	47.49	54	49.51	34.17	168.32
Depreciation	-9.94	-9.30	-7.85	-8.09	-6	-31.25
EBIT	43.82+55.6%	38.19	46.15	41.42	28.17	137.07
PBT	39.46+49.0%	47.40	44.60	40.64	26.49	159.10
Tax	-9.01	-10.73	-11.02	-10.52	-5.31	-37.57
Equity	46.05	46.05	0	46.05	46.05	46.05
OPM	21.56	24.58	25.01	24.31	18.74	23.41
Net Profit	30.45+43.8%	36.67	33.58	30.12	21.18	121.53
NPM	16.64	19.01	18.83	18.02	14.98	17.88
EPS	6.61+43.7%	7.96	7.29	6.54	4.60	26.39

Yearly results

Last 6 financial years · YoY % vs previous FY

Metric	FY 25-26	FY 24-25
Revenue	632.63+58.9%	398.25
Other Income	47.06	19.26
Total Income	679.69+62.8%	417.51
Expenditure	-520.59-50.1%	-346.94
Interest	-25.03	-21.55
PBDT	0	0
EBITDA	168.32+87.6%	89.70
Depreciation	-31.25	-16.84
EBIT	137.07+88.1%	72.86
PBT	159.10+125.4%	70.57
Tax	-37.57	-12.23
Equity	46.05	46.05
OPM (%)	23.41	16.90
Net Profit	121.53+108.3%	58.34
NPM (%)	17.88	13.97
EPS (Rs)	26.39+63.7%	16.12
CEPS	26.39	16.12

Corporate Actions

Dividends, bonus issues, and stock splits

Dividend

No dividend history.

Bonus

No bonus history.

Split

No split history.

Financial Results

Standalone

Yearly results

Yearly

Consolidated

Yearly results

Yearly

Corporate Actions

Dividend

Bonus

Split